Skip to main content
English
中文
Log In
Log in
Log in with ORCID
NTU Single Sign On
Have you forgotten your password?
Home
College of Medicine / 醫學院
Oncology / 腫瘤醫學研究所
Active or Attractive? Oral Antiangiogenesis Therapy Plus EGFR Tyrosine Kinase Inhibitor in EGFR-Mutant NSCLC
Details
Active or Attractive? Oral Antiangiogenesis Therapy Plus EGFR Tyrosine Kinase Inhibitor in EGFR-Mutant NSCLC
Journal
Journal of Thoracic Oncology
Journal Volume
16
Journal Issue
9
Date Issued
2021-09-01
Author(s)
BIN-CHI LIAO
CHIH-HSIN YANG
DOI
10.1016/j.jtho.2021.06.028
URI
https://scholars.lib.ntu.edu.tw/handle/123456789/582855
URL
https://api.elsevier.com/content/abstract/scopus_id/85113798020
SDGs
[SDGs]SDG3
Type
other